ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHEUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTF31

Dynamics of Developmental Defect Formation

Active
Institution
PRINCETON UNIVERSITY, NJ
Principal investigator
Alison Simpkins
Funding
$34K
Duration
2025–2027
Open portfolio

Moonbase score

Still being scored

Abstract

PROJECT SUMMARY Recent advances in genome sequencing have led to the identification of many mutations linked to developmental disorders. Additionally, phenotypes associated with these diseases have been well characterized through endpoint assays. Thus, genotype and phenotype have been separately well defined, but the connection between the two is not clear. Identifying the point in development that is most vulnerable to the effects of these mutations, or the point at which there is a detectable difference from what is typically observed is essential for understanding the pathogenesis of developmental disorders. To address these outstanding questions, live imaging approaches are needed. The proposed work uses the larval tracheal system of Drosophila as a model for the study of phenotypic emergence. The development of the larval tracheal system is strikingly analogous to human angiogenesis, a process that is affected in a class of developmental diseases known as the RASopathies, the subject of this work. Using this model system in Drosophila gene edited to carry mutations leading to elevated Ras-MAPK signaling, the proposed work will identify the position and timing of defect formation as well as the magnitude of change in signaling that accompanies developmental defect formation. Specifically, Aim 1 will use endogenous live reporters of tracheal cell fates in combination with live imaging to identify the developmental event that is affected in a mutant background. This work will provide insight into the variability underlying phenotypic emergence. Additionally, Aim 2 will use live reporters of signaling pathways, live imaging, and quantitative image analysis to determine the magnitude of change in signaling activity that is associated with a change in cell fate or the formation of a defect. The work described in Aim 2 will identify the limits of robustness of developmental signaling pathways. The proposed studies, which are supported by strong preliminary results, including live imaging and an established image analysis pipeline, will provide a deeper understanding of the connection between genotype and phenotype.

LOADING MOONBASE SCORE

F31EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTSpecial Emphasis Panel[ZRG1 F05-Q (20)]developmentallive imagingdevelopmental disordersgenotype phenotypereporterslivedefectlarval

Questions for PRINCETON UNIVERSITY

Answered by the team behind this research.

Same institution, same topic, scored first.